Elutia Inc (ELUT) vs Harvard Bioscience, Inc. (HBIO)
A side-by-side comparison of Elutia Inc and Harvard Bioscience, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ELUT
Elutia Inc
$0.81HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
HBIO
Harvard Bioscience, Inc.
$8.51HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
Total return — ELUT vs HBIO
growth of $100 · dividends reinvested · last 6yELUT -94.3% (-38.0%/yr)HBIO -71.9% (-19.0%/yr)HBIO compounded faster over this window
ELUT HBIO
ELUT vs HBIO: by the numbers
- •HBIO is the larger company ($38M vs $36M market cap).
- •ELUT is profitable (426.93% net margin) while HBIO runs a net loss (-11.86%).
- •Both shrank revenue over the past five years; HBIO's decline was smaller (-4.62% vs -22.04% CAGR).
Metrics side by side
Valuation
| Metric | ELUT | HBIO |
|---|---|---|
| P/E ratio | 0.86 | N/A |
| P/S ratio | 2.94 | 0.44 |
| P/B ratio | 2.27 | 5.17 |
| EV / EBITDA | N/A | 10.51 |
Profitability
| Metric | ELUT | HBIO |
|---|---|---|
| Gross margin | 57.82% | 58.16% |
| Operating margin | -149.78% | 1.17% |
| Net margin | 426.93% | -11.86% |
| ROE | 329.02% | -140.36% |
| ROIC | -79.27% | 1.99% |
Growth (annualized)
| Metric | ELUT | HBIO |
|---|---|---|
| Revenue CAGR (5Y) | -22.04% | -4.62% |
| Total return CAGR (5Y) | -33.96% | -34.33% |
Frequently asked
- Which has grown faster, ELUT or HBIO?
- Neither grew: over the past five years both shrank revenue, with HBIO's decline the smaller — ELUT at a -22.04% CAGR versus HBIO at -4.62%.
- Is ELUT or HBIO more profitable?
- ELUT runs the higher net margin — ELUT at 426.93% versus HBIO at -11.86%.
- How have ELUT and HBIO total returns compared?
- Over the past 5 years, ELUT delivered -33.96% and HBIO delivered -34.33% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Elutia P/E ratioElutia ROEHarvard Bioscience ROEElutia operating marginHarvard Bioscience operating marginElutia revenue growthHarvard Bioscience revenue growthElutia free cash flowHarvard Bioscience free cash flow
Elutia & Harvard Bioscience appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.